Epithalon 50 - Ultima Pharmaceuticals

Epithalon’s history began with Russian researchers at Saint Petersburg University, who identified it by analyzing epithalamin. Since the 1990s, epithalamin has been widely used in Russia for longevity purposes, and Epithalon was first introduced in 1999 at an international geriatrics congress. This peptide remains an experimental compound and is used primarily as a research agent in studies on aging and cellular health. Its mechanism isn’t fully understood, but it is suspected to act on unidentified receptors in cell membranes, facilitating biological repair processes​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Epithalon 50 by Ultima Pharmaceuticals, consult with your doctor or healthcare professional.